The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 01, 2022

Filed:

Sep. 22, 2017
Applicants:

Emory University, Atlanta, GA (US);

Rutgers, the State University of New Jersey, New Brunswick, NJ (US);

Inventors:

Arash Grakoui, Decatur, GA (US);

Joseph Marcotrigiano, New Brunswick, NJ (US);

Assignees:

Emory University, Atlanta, GA (US);

Rutgers, the State University of New Jersey, New Brunswick, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/21 (2006.01); C12N 7/00 (2006.01); A61K 39/12 (2006.01); C12N 15/00 (2006.01); C07K 16/10 (2006.01); C12N 15/10 (2006.01); C12Q 1/686 (2018.01);
U.S. Cl.
CPC ...
C07K 16/109 (2013.01); C07K 16/1063 (2013.01); C12N 15/1006 (2013.01); C12Q 1/686 (2013.01); C12N 2740/16122 (2013.01); C12N 2770/24222 (2013.01);
Abstract

The present disclosure relates to constructs useful in expressing biotinylated monomers and tetramers produced from these monomers. Specifically, the disclosure provides a construct useful in expressing biotinylated antigen monomers, said construct comprising a viral protein of an ectodomain of Hepatitis C Virus (HCV) envelope glycoprotein E2 or Human Immunodeficiency Virus (HIV) gp140. Further disclosed are methods for production and use of these tetramers in identifying and isolating antigen specific B cells and cloning antibodies thereto.


Find Patent Forward Citations

Loading…